Chijet Motor Company, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement

Chijet Motor Company, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire November 18, 2025 New York, Nov. 18, 2025 (GLOBE NEWSWIRE) — CHIJET MOTOR COMPANY, INC. (NASDAQ: CJET) (the “Company”) today announced that it has received a notification letter (“Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) […]

INNEOVA Holdings’ CEO Issues Letter to Shareholders

INNEOVA Holdings' CEO Issues Letter to Shareholders GlobeNewswire November 18, 2025 Charting INEO's Next Chapter: Powering a Sustainable and Intelligent Future SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) — INNEOVA Holdings Limited (“INNEOVA Holdings” or the “Company”) (Nasdaq: INEO), a Singapore-based engineering solutions provider that maximizes equipment uptime, optimizes total cost of ownership, and extends asset

Plug Power Hosts Seventh Annual Symposium Highlighting Hydrogen’s Role in Energy Independence

Plug Power Hosts Seventh Annual Symposium Highlighting Hydrogen's Role in Energy Independence GlobeNewswire November 18, 2025 SLINGERLANDS, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in hydrogen solutions for the hydrogen economy, is hosting its seventh annual Plug Power Symposium at the Company's headquarters and manufacturing facility in

Amplify ETFs Launches the Amplify XRP 3% Monthly Premium Income ETF (XRPM)

Amplify ETFs Launches the Amplify XRP 3% Monthly Premium Income ETF (XRPM) XRPM aims for XRP growth exposure and 36% annual option income GlobeNewswire November 18, 2025 CHICAGO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Amplify ETFs, a leading provider of breakthrough ETF solutions, announces the launch of the first XRP-based option income ETF, Amplify XRP

Mesa Air Group Shareholders Approve Merger with Republic Airways

Mesa Air Group Shareholders Approve Merger with Republic Airways GlobeNewswire November 18, 2025 PHOENIX, Nov. 18, 2025 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (“Mesa” or the “Company”) (Nasdaq: MESA) announced today that shareholders approved all proposals presented at the Company's special meeting of shareholders, including the proposal to adopt the agreement and plan of

FINAL NOTICE: Kaskela Law LLC Announces Investigation into Proposed $59.00 Per Share Buyout of Heidrick & Struggles (NASDAQ: HSII) Stockholders and Encourages Investors to Contact the Firm to Protect Their Investment

FINAL NOTICE: Kaskela Law LLC Announces Investigation into Proposed $59.00 Per Share Buyout of Heidrick & Struggles (NASDAQ: HSII) Stockholders and Encourages Investors to Contact the Firm to Protect Their Investment GlobeNewswire November 18, 2025 PHILADELPHIA , Nov. 18, 2025 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating the fairness of the recently

SHAREHOLDER ALERT: Kaskela Law LLC Announces Probe into Fairness of Electronic Arts Inc. (EA) Proposed $210.00 Per Share Buyout and Encourages Investors to Contact the Firm

SHAREHOLDER ALERT: Kaskela Law LLC Announces Probe into Fairness of Electronic Arts Inc. (EA) Proposed $210.00 Per Share Buyout and Encourages Investors to Contact the Firm GlobeNewswire November 18, 2025 PHILADELPHIA , Nov. 18, 2025 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating the recently announced proposed buyout of Electronic Arts Inc. (NASDAQ:

Esperion Partner HLS Therapeutics Announces Approval of NILEMDO(R) for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease

Esperion Partner HLS Therapeutics Announces Approval of NILEMDO(R) for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease GlobeNewswire November 18, 2025 ANN ARBOR, Mich., Nov. 18, 2025 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that HLS Therapeutics Inc. (TSX: HLS), the Company's partner in Canada for the development and commercialization of

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals GlobeNewswire November 18, 2025 NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition of Melt Pharmaceuticals, Inc. (Melt), a clinical-stage pharmaceutical company pioneering non-opioid, non-IV therapies

Scroll to Top